John Mauric
Family Medicine · Fremont, OHNPI 1891731659
Payments from drug & device makers
Across 76 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$342
- Inspire Medical Systems, Inc.$151
- GSK$139
- Lilly USA, LLC$129
- Merck$85
- Boehringer Ingelheim$65
- plus $557 from 25 others
What the payments were for
- Food & beverage$1,467100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $342 |
| Inspire Medical Systems, Inc. | 1 | $151 |
| GSK | 2 | $139 |
| Lilly USA, LLC | 8 | $129 |
| Merck | 6 | $85 |
| Boehringer Ingelheim | 4 | $65 |
| Organogenesis Inc. | 1 | $51 |
| Boston Scientific | 1 | $42 |
| Alkermes, Inc. | 2 | $39 |
| AstraZeneca | 3 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Gilead | 2 | $31 |
| Novo Nordisk | 2 | $28 |
| Pfizer | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Mimedx Group, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Quidel Corporation | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $16 |
| Solventum Corporation | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Bayer | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Organon | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,467 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 11 | $16,245 |
| OzempicSemaglutide | 14 | $13,582 |
| InvokanaCanagliflozin | 13 | $7,286 |
| Levothyroxine Sodium | 16 | $229 |
| Escitalopram Oxalate | 13 | $129 |
| Pioglitazone Hcl | 13 | $120 |
| Atorvastatin Calcium | 18 | $111 |
| Lisinopril | 19 | $97 |
| Quetiapine Fumarate | 11 | $89 |
| Simvastatin | 19 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $342 | $16,24511 claims |
| Novo NordiskOzempic | $28 | $13,58214 claims |
| Johnson & JohnsonInvokana | $11 | $7,28613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Fremont
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.